{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:09:40Z","timestamp":1788311380880,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Wuhan Municipal Health Commission","award":["WX21M03, WX21Q50"],"award-info":[{"award-number":["WX21M03, WX21Q50"]}]},{"name":"Natural Science Foundation of Wuhan Science and Technology Bureau","award":["2022020801020573"],"award-info":[{"award-number":["2022020801020573"]}]},{"name":"Natural Science Foundation of Hubei Municipal Health Commission","award":["WJ2021M016"],"award-info":[{"award-number":["WJ2021M016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Children with\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia (MPP) are prone to a missed diagnosis at the early stages of the disease, which greatly affects the prognosis of children. In this study, the application value of\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      (MP) antibody titres and RNA detection for diagnosing MP infection in children with community-acquired pneumonia (CAP) was evaluated. The present study aimed to seek appropriate detection methods and strategies for early rapid diagnosis in children with MPP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study was conducted on 563 paediatric patients aged 1 month to 15 years with CAP who were admitted to Wuhan Children\u2019s Hospital, Tongji Medical College, Huazhong University of Science and Technology between July 2021 and February 2022. In all patients, throat swabs were collected for MP-RNA detection (simultaneous amplification and testing, SAT), and paired serum samples were collected for MP total antibody detection (particle agglutination, PA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The classification as MPP or non-MPP was based on clinical diagnosis, serum MP antibody titre, and clinical or laboratory evidence of infection by other pathogen(s). Among the 563 patients with pneumonia, 187 patients were in the MPP group, and 376 patients were in the non-MPP group. The Kappa values between the particle agglutination test at different titres (1:80, 1:160) and MP-RNA detection were 0.612 and 0.660 (\n                      <jats:italic>P&lt;0.01<\/jats:italic>\n                      ), and the consistency of the three methods was acceptable. When the single screening method was used, MP-RNA had the highest sensitivity (93.05%), while PA (1:160) had the highest specificity (100%). PA (1:80), with an area under the curve (AUC) of 0.822, was better than PA (1:160), with an AUC of 0.783, and there was a significant difference. When the combined screening methods were used, the AUC of MP-RNA parallel PA (1:160) was significantly higher than that of titres (1:80) (z=-4.906,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). Except for MP-80, the efficacy of the other three test methods in females was slightly better than that in males. Among the differences in age distribution, PA (1:80) was slightly less effective in the 13\u201372 months age group than at other ages, and MP-RNA parallel PA (1:160) was slightly better than the younger age group (\u2264\u200936\u00a0m). In the older age group (&gt;\u200936\u00a0m), PA (1:160) was just the opposite, while MP-RNA was slightly better than other age groups in the 13\u201372 months age group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For the diagnosis of MPP in children at the early of the disease, the antibody titre (1:160) parallel MP-RNA should be given preference, and then the disease should be further classified according to the antibody titre level and the age of the child. The combined application of the two detection methods could complement each other and strengthen the advantages, providing reliable laboratory evidence for the clinical diagnosis and timely treatment of MPP. When using the PA method alone to provide a reference standard to clarify MP infection, the differential diagnosis ability of 1:80 for MPP is better than 1:160, especially for children younger than 36 months.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08161-8","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T11:02:50Z","timestamp":1680865370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Application value of antibody titres and RNA detection in the early prediction of Mycoplasma pneumoniae pneumonia in children: a retrospective study"],"prefix":"10.1186","volume":"23","author":[{"given":"Wenbin","family":"Tuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinzhen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,7]]},"reference":[{"issue":"9","key":"8161_CR1","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1080\/14656566.2021.1882420","volume":"22","author":"S Esposito","year":"2021","unstructured":"Esposito S, Argentiero A, Gramegna A, Principi N. Mycoplasma pneumoniae: a pathogen with unsolved therapeutic problems. Expert Opin Pharmacother. 2021;22(9):1193\u2013202.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"8161_CR2","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s12879-022-07456-6","volume":"22","author":"S Choo","year":"2022","unstructured":"Choo S, Kim S, Lee E. Clinical significance of Mycoplasma pneumoniae specific IgM titer in children hospitalized with Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2022;22(1):470.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"8161_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/ijmr.IJMR_1582_16","volume":"147","author":"S Kumar","year":"2018","unstructured":"Kumar S. Mycoplasma pneumoniae: a significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections. Indian J Med Res. 2018;147(1):23\u201331.","journal-title":"Indian J Med Res"},{"issue":"1","key":"8161_CR4","first-page":"5","volume":"68","author":"PK Kutty","year":"2019","unstructured":"Kutty PK, Jain S, Taylor TH, Bramley AM, Diaz MH, Ampofo K, et al. Mycoplasma pneumoniae among children hospitalized with community-acquired Pneumonia. Clin Infect Dis. 2019;68(1):5\u201312.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8161_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.diagmicrobio.2019.03.010","volume":"95","author":"S Kumar","year":"2019","unstructured":"Kumar S, Garg IB, Sethi GR. Serological and molecular detection of Mycoplasma pneumoniae in children with community-acquired lower respiratory tract infections. Diagn Microbiol Infect Dis. 2019;95(1):5\u20139.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"8161_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/jcla.20390","volume":"24","author":"L Ma","year":"2010","unstructured":"Ma L, Chen B, Dong Y, Fan J, Xia L, Wang S, et al. Rapid mycoplasma culture for the early diagnosis of Mycoplasma pneumoniae infection. J Clin Lab Anal. 2010;24(4):224\u20139.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"8161_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12887-021-02523-4","volume":"21","author":"M Tang","year":"2021","unstructured":"Tang M, Wang D, Tong X, Wu Y, Zhang J, Zhang L, et al. Comparison of different detection methods for Mycoplasma pneumoniae infection in children with community-acquired pneumonia. BMC Pediatr. 2021;21(1):90.","journal-title":"BMC Pediatr"},{"key":"8161_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijid.2019.03.028","volume":"83","author":"J Qu","year":"2019","unstructured":"Qu J, Chen S, Bao F, Gu L, Cao B. Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China. Int J Infect Dis. 2019;83:26\u201331.","journal-title":"Int J Infect Dis"},{"key":"8161_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fped.2019.00441","volume":"7","author":"J Li","year":"2019","unstructured":"Li J, Sun L, Wu X, Guo Y, Jiao W, Xiao J, et al. Early diagnosis of Mycoplasma pneumoniae in children: simultaneous amplification and testing (SAT) is the Key. Front Pediatr. 2019;7:441.","journal-title":"Front Pediatr"},{"issue":"1","key":"8161_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12879-020-05036-0","volume":"20","author":"T Li","year":"2020","unstructured":"Li T, Shi T, Sun Y, Zhou K, Huang Z, Wang P, et al. Application of real-time simultaneous amplification and testing method to accurately and rapidly detect extra-pulmonary tuberculosis. BMC Infect Dis. 2020;20(1):303.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"8161_CR11","doi-asserted-by":"publisher","first-page":"e0177842","DOI":"10.1371\/journal.pone.0177842","volume":"12","author":"W Li","year":"2017","unstructured":"Li W, Fang YH, Shen HQ, Yang DH, Shu Q, Shang SQ. Evaluation of a real-time method of simultaneous amplification and testing in diagnosis of Mycoplasma pneumoniae infection in children with pneumonia. PLoS ONE. 2017;12(5):e0177842.","journal-title":"PLoS ONE"},{"issue":"7","key":"8161_CR12","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1097\/INF.0000000000002636","volume":"39","author":"AR Copete","year":"2020","unstructured":"Copete AR, Vera C, Herrera M, Aguilar YA, Rueda ZV, Velez LA. Mycoplasma pneumoniae in children with and without community-acquired Pneumonia. What do PCR and serology say? Pediatr Infect Dis J. 2020;39(7):e104\u2013e8.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"8161_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1186\/s12879-017-2614-3","volume":"17","author":"L Wang","year":"2017","unstructured":"Wang L, Feng Z, Zhao M, Yang S, Yan X, Guo W, et al. A comparison study between GeXP-based multiplex-PCR and serology assay for Mycoplasma pneumoniae detection in children with community acquired pneumonia. BMC Infect Dis. 2017;17(1):518.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"8161_CR14","first-page":"366","volume":"58","author":"C Family Planning","year":"2020","unstructured":"Expert Committee on Rational Use of Medicines for Children Pharmaceutical Group NH, Family Planning C. [Expert consensus on laboratory diagnostics and clinical practice of Mycoplasma pneumoniae infection in children in China (2019)]. Zhonghua Er Ke Za Zhi. 2020;58(5):366\u201373.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"5","key":"8161_CR15","first-page":"366","volume":"58","author":"C Family Planning","year":"2020","unstructured":"Expert Committee on Rational Use of Medicines for Children Pharmaceutical Group NH, Family Planning C. Mycoplasma pneumoniae[Expert consensus on laboratory diagnostics and clinical practice of infection in children in China (2019)]. Zhonghua er ke za zhi = Chinese. J Pediatr. 2020;58(5):366\u201373.","journal-title":"J Pediatr"},{"key":"8161_CR16","unstructured":"Respiratory Branch of Chinese Pediatric Society of Chinese Medical Association,Editorial Board of Chinese Journal of Applied Clinical Pediatrics. Expert consensus on diagnosis and treatment of mycoplasma pneumoniae pneumonia in children(2015),Chin J Appl Clin Pediatr, September 2015, Vol.30, No.17"},{"issue":"1","key":"8161_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14787210.2018.1414599","volume":"16","author":"H Lee","year":"2018","unstructured":"Lee H, Yun KW, Lee HJ, Choi EH. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev Anti Infect Ther. 2018;16(1):23\u201334.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"9","key":"8161_CR18","first-page":"737","volume":"20","author":"D Chen","year":"2018","unstructured":"Chen D, Sun X, Guo M, Guo Q, Zhang G, Ren Y. [Value of simultaneous amplification and testing in early diagnosis of Mycoplasma pneumoniae pneumonia and related influencing factors]. Zhongguo dang dai er ke za zhi = Chinese. J Contemp Pediatr. 2018;20(9):737\u201341.","journal-title":"J Contemp Pediatr"},{"issue":"5","key":"8161_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s10156-012-0388-5","volume":"18","author":"K Gotoh","year":"2012","unstructured":"Gotoh K, Nishimura N, Ohshima Y, Arakawa Y, Hosono H, Yamamoto Y, et al. Detection of Mycoplasma pneumoniae by loop-mediated isothermal amplification (LAMP) assay and serology in pediatric community-acquired pneumonia. J Infect Chemother. 2012;18(5):662\u20137.","journal-title":"J Infect Chemother"},{"issue":"1","key":"8161_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12879-020-05110-7","volume":"20","author":"B Zheng","year":"2020","unstructured":"Zheng B, Zhao J, Cao L. The clinical characteristics and risk factors for necrotizing pneumonia caused by Mycoplasma pneumoniae in children. BMC Infect Dis. 2020;20(1):391.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08161-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08161-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08161-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T11:03:48Z","timestamp":1680865428000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08161-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8161"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08161-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1884021\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,7]]},"assertion":[{"value":"22 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The protocols used in this retrospective study were reviewed and approved by the institutional ethics board of Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology (NO.: 2022R048-E01). The requirement for individual informed consent was waived by the ethics committee listed above because this study used currently existing medical records collected during the course of routine medical care and did not pose any additional risks to the patients. All patient data were anonymized prior to the analysis. Any administrative permissions and\/or licences were acquired by the ethics committee of the Wuhan Children\u2019s Hospital, Tongji Medical College, Huazhong University of Science & Technology to access the data used in our research. All methods were performed in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"220"}}